Immvira Co.
Latest round
- Series C
Last raised
- Dec 2020
Total raised
- $83M
Investors
- 17
About Immvira Co.
, Ltd. is a biotechnology company that focuses on the R&D of anti-cancer drug vectors. In 2020, the MVR-T3011 Phase I clinical trial began to do in China and Australia. In 2021, the MVR-T3011 IT phase II received the first patient enrolled (FPI) in China and the US, and MVR-T3011 IV received Investigational New Drug (IND) approval in China. Dr. Grace Zhou, the company's CEO, developed engineering recombinant oncolytic herpes simplex viruses (OHSV) technology to treat cancer., Ltd. provides anti-cancer drug vectors based on OHSV technology. Anti-cancer drug vectors include replicating and non-replicating herpes simplex virus vectors, drug delivery exosomes, and tumor vaccines. And drug delivery methods include intravenous, intraperitoneal, pleural, and vesical injections. Its three oncolytic virus products have been in phase I and phase II clinical trials.
Who invested in Immvira Co.
17 investors across 5 rounds
See all investors in Immvira Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Immvira Co.
Who invested in Immvira Co.?
Immvira Co. has 17 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Immvira Co. raised?
Immvira Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Immvira Co. last raise money?
Immvira Co.'s most recent round on record is a Series C, in Dec 2020.
What does Immvira Co. do?
Immvira Co. is a biotechnology company.
Where is Immvira Co. headquartered?
Immvira Co. is headquartered in Shenzhen, China.
Which VCs invest in companies like Immvira Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Immvira Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Immvira Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.